Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Bioventus Inc. (BVS) had Debt to Capital Ratio of 0.55 for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$157.90M |
|
$14.76M |
|
$49.12M |
|
$108.78M |
|
$138.41M |
|
$19.49M |
|
$-5.34M |
|
$14.14M |
|
$14.14M |
|
$17.32M |
|
$17.32M |
|
$17.32M |
|
$17.32M |
|
$19.49M |
|
$31.18M |
|
66.62M |
|
68.91M |
|
$0.22 |
|
$0.21 |
|
| Balance Sheet Financials | |
$272.84M |
|
$21.90M |
|
$410.72M |
|
$683.56M |
|
$160.38M |
|
$278.95M |
|
$294.73M |
|
$455.11M |
|
$228.45M |
|
$-147.43M |
|
$228.45M |
|
82.89M |
|
| Cash Flow Statement Financials | |
$74.67M |
|
$-3.25M |
|
$-62.14M |
|
$41.58M |
|
$51.24M |
|
$9.66M |
|
$12.67M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.70 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.55 |
1.29 |
|
68.89% |
|
12.34% |
|
12.34% |
|
-- |
|
8.96% |
|
9.34% |
|
$72.11M |
|
-- |
|
-- |
|
-- |
|
0.23 |
|
0.60 |
|
1.23 |
|
73.13 |
|
7.58% |
|
-11.75% |
|
2.53% |
|
3.41% |
|
$2.76 |
|
$1.05 |
|
$1.08 |
|